Immune checkpoint inhibitors as first-line and salvage therapy for advanced non-small-cell lung cancer

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd013257.pub2 ◽

2020 ◽

Author(s):

Roberto Ferrara ◽

Martina Imbimbo ◽

Reem Malouf ◽

Sophie Paget-Bailly ◽

François Calais ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Platinum Based Chemotherapy

First-Line Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Landscape and Future Progress

Frontiers in Pharmacology ◽

10.3389/fphar.2020.578091 ◽

2020 ◽

Vol 11 ◽

Author(s):

Zhangfeng Huang ◽

Wenhao Su ◽

Tong Lu ◽

Yuanyong Wang ◽

Yanting Dong ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Single or combined immune checkpoint inhibitors compared to first-line chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd013257 ◽

2019 ◽

Cited By ~ 1

Author(s):

Roberto Ferrara ◽

Martina Imbimbo ◽

Sophie Paget-Bailly ◽

Reem Malouf ◽

François Calais ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Line Chemotherapy

P1.04-67 First-Line Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer (NSCLC) – A Network Meta-Analysis by PD-L1

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.970 ◽

2019 ◽

Vol 14 (10) ◽

pp. S467

Author(s):

P. San Tan ◽

P. Nazareth Aguiar Junior ◽

M. Husnain ◽

B. Haaland ◽

G. Lopes

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Immune checkpoint inhibitors (ICI) in combination with chemotherapy as first-line (1L) treatment for non-small cell lung cancer (NSCLC): A pair-wise meta-analysis (MA)

Annals of Oncology ◽

10.1093/annonc/mdz451.025 ◽

2019 ◽

Vol 30 ◽

pp. xi43

Author(s):

F.J. Afonso-Afonso ◽

M. Amenedo Gancedo ◽

M.C. Areses Manrique ◽

B. Campos Balea ◽

J. Casal Rubio ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd013257.pub3 ◽

2021 ◽

Author(s):

Roberto Ferrara ◽

Martina Imbimbo ◽

Reem Malouf ◽

Sophie Paget-Bailly ◽

François Calais ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Platinum Based Chemotherapy

P09.25 Role of Immune Checkpoint Inhibitors (ICPi) in KRAS-Mutated Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.453 ◽

2021 ◽

Vol 16 (3) ◽

pp. S300-S301

Author(s):

M. Peravali ◽

C. Gomes-Lima ◽

E. Tefera ◽

M. Baker ◽

M. Sherchan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung

A single institution study evaluating outcomes of PD-L1 high KRAS-mutant advanced non-small cell lung cancer (NSCLC) patients treated with first line immune checkpoint inhibitors

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2021.100330 ◽

2021 ◽

Vol 27 ◽

pp. 100330 ◽

Cited By ~ 1

Author(s):

Adi Kartolo ◽

Harriet Feilotter ◽

Wilma Hopman ◽

Andrea S. Fung ◽

Andrew Robinson

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung ◽

Single Institution ◽

First Line ◽

Nsclc Patients

FP12.05 Molecular Landscape of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Chinese Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.131 ◽

2021 ◽

Vol 16 (3) ◽

pp. S218-S219

Author(s):

X. Niu ◽

Z. Zhou ◽

Y. Yu ◽

L. Shen ◽

K. Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Acquired Resistance ◽

Small Cell ◽

Small Cell Lung ◽

Molecular Landscape

Concomitant use of analgesics and immune checkpoint inhibitors in non-small cell lung cancer: A pharmacodynamics perspective

European Journal of Pharmacology ◽

10.1016/j.ejphar.2021.174284 ◽

2021 ◽

pp. 174284

Author(s):

Rahmad Aji Prasetya ◽

Marjolein Metselaar-Albers ◽

Ferdi Engels

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Small Cell ◽

Small Cell Lung